Halstead Michael
This company's Exchange Act registration has been revoked
This company's Exchange Act registration as a Municipal Advisor has been revoked
This company's Exchange Act registration as a Municipal Advisor has been cancelled
[+] Company Information
CIK:
0001521548
0001521548
EIN:
LEI:
SIC:
(CF Office: )
State location:
State of
incorporation:
Fiscal year end:
Business address:
Phone:
Phone:
Mailing address:
C/O INTRA-CELLULAR THERAPIES, INC., 135 ROUTE 202/206, BEDMINSTER, NJ, 07921
C/O INTRA-CELLULAR THERAPIES, INC., 135 ROUTE 202/206, BEDMINSTER, NJ, 07921
Category:
Filings:
70 EDGAR filings since June 2, 2011
70 EDGAR filings since June 2, 2011
Get insider transactions
for this issuer
Get insider transactions
for this reporting owner
Latest Filings (excluding insider transactions)
- November 12, 2024 - 144: Report of proposed sale of securities Open documentClick to Open document FilingOpen filingClick to Open filing
- March 11, 2024 - 144: Report of proposed sale of securities Open documentClick to Open document FilingOpen filingClick to Open filing
- March 7, 2024 - 144: Report of proposed sale of securities Open documentClick to Open document FilingOpen filingClick to Open filing
- February 26, 2024 - 144: Report of proposed sale of securities Open documentClick to Open document FilingOpen filingClick to Open filing
- February 2, 2024 - 144/A: Report of proposed sale of securities - amendmentOpen documentClick to Open document FilingOpen filingClick to Open filing
Selected Filings
[+] 8-K (current reports)
No 8-K filing data for this company in last 110 days
[+] 10-K (annual reports) and 10-Q (quarterly reports)
No 10-K/10-Q filings for this company in last 365
days
[+] Proxy (annual meeting) and information statements
No Proxy filings for this company in last 365 days
[+] Ownership disclosures
- Insider transactions
- March 10, 2025 - 4: Statement of changes in beneficial ownership of securities Open documentClick to Open document FilingOpen filingClick to Open filing
- March 4, 2025 - 4: Statement of changes in beneficial ownership of securities Open documentClick to Open document FilingOpen filingClick to Open filing
- February 4, 2025 - 4: Statement of changes in beneficial ownership of securities Open documentClick to Open document FilingOpen filingClick to Open filing
- Beneficial ownership (Schedule 13D and 13G)
No beneficial ownership filings for this company in last 365 days
Filings
| Form type | Form description | Filing date | Reporting date |
|---|
0
Showing 1 to 48 of 70 entries
Data source:
CIK0001521548.json
There is no filings data for
this organization
Investor Resources
How to Use EDGAR
Learn how to use EDGAR to research public filings by public companies, mutual funds, ETFs, some annuities, and more.
Before you Invest, Investor.gov
Get answers to your investing questions from the SEC's website dedicated to retail investors
